Upregulation of FASN enhances CRC growth and spread through the AMPK/mTOR signaling pathway and is associated with secondary lymph node involvement, tumor stage (TNM), and poorer CRC outcomes (207). The gene discussed is MTOR; the disease is neoplasm.